# Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

> **NCT00688428** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 84 (estimated)

## Conditions studied

- Ulcers
- Upper GI Symptoms

## Interventions

- **DRUG:** Esomeprazole 40mg/ASA 325mg
- **DRUG:** Esomeprazole
- **DRUG:** ASA

## Key facts

- **NCT ID:** NCT00688428
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2009-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688428, "Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00688428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*